Abstract
The heart and vascular system represent major targets of the thyroid hormone action, and marked changes occur in cardiac electro-mechanical function of patients with hyper-hypothyroidism. Thyroid hormones exert their effects through both genomic (nuclear) and nongenomic (extranuclear) mechanisms. Understanding the cellular mechanisms of thyroid hormone action on the heart and cardiovascular system is the basis to explain the changes in cardiac output, cardiac contractility, blood pressure, vascular resistance, and rhythm abnormalities secondary to thyroid dysfunction. Not only overt, but also subclinical thyroid diseases have been associated with systolic and diastolic cardiac abnormalities, and with alterations of well known cardiovascular risk factors. Moreover, the early diagnosis and treatment of thyroid diseases restore to normal most of the cardiovascular changes. Nowadays, it is becoming increasingly evident that, like a vicious circle, acute and chronic cardiovascular diseases may influence thyroid hormone metabolism, which, in turn, can contribute to cardiovascular impairment progression.
Keywords: Thyroid hormones, cardiovascular disease, thyroid dysfunction
Current Drug Therapy
Title: Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Volume: 5 Issue: 1
Author(s): Pasquale Di Conza, Flora Affuso and Serafino Fazio
Affiliation:
Keywords: Thyroid hormones, cardiovascular disease, thyroid dysfunction
Abstract: The heart and vascular system represent major targets of the thyroid hormone action, and marked changes occur in cardiac electro-mechanical function of patients with hyper-hypothyroidism. Thyroid hormones exert their effects through both genomic (nuclear) and nongenomic (extranuclear) mechanisms. Understanding the cellular mechanisms of thyroid hormone action on the heart and cardiovascular system is the basis to explain the changes in cardiac output, cardiac contractility, blood pressure, vascular resistance, and rhythm abnormalities secondary to thyroid dysfunction. Not only overt, but also subclinical thyroid diseases have been associated with systolic and diastolic cardiac abnormalities, and with alterations of well known cardiovascular risk factors. Moreover, the early diagnosis and treatment of thyroid diseases restore to normal most of the cardiovascular changes. Nowadays, it is becoming increasingly evident that, like a vicious circle, acute and chronic cardiovascular diseases may influence thyroid hormone metabolism, which, in turn, can contribute to cardiovascular impairment progression.
Export Options
About this article
Cite this article as:
Conza Di Pasquale, Affuso Flora and Fazio Serafino, Thyroid Hormones and Cardiovascular System: From Bench to Bedside, Current Drug Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/1574885511005010036
DOI https://dx.doi.org/10.2174/1574885511005010036 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Renal Phosphate Handling in Antiretroviral-naive HIV-Infected Patients
Infectious Disorders - Drug Targets Ageing as a Trait de Union Between Diabetes and Dementia for Frailty
CNS & Neurological Disorders - Drug Targets Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Cardiovascular Magnetic Resonance T2-weighted Imaging of Myocardial Edema in Acute Myocardial Infarction
Recent Patents on Cardiovascular Drug Discovery The Pathophysiological Basis of Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
Current Vascular Pharmacology Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Antithrombotic Therapy After TAVR
Current Vascular Pharmacology Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design Beta-Blockers are Associated with Decreased In-Hospital Mortality and Stroke in Acute Decompensated Heart Failure: Findings from a Retrospective Analysis of a 22-Year Registry in the Middle East (1991-2013)
Current Vascular Pharmacology Marine Lipids and the Bioavailability of <i>Omega</i>-3 Fatty Acids
Current Nutrition & Food Science Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Targets
Current Pharmaceutical Design Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology Molecular and Biochemical Changes of the Cardiovascular System due to Smoking Exposure
Current Pharmaceutical Design Detection of Biothiols Using Some Novel Chemosensors: An Overview
Mini-Reviews in Organic Chemistry Adrenergic and V1-ergic Agonists/Antagonists Affecting Recovery from Brain Trauma in the Lund Project Act on Astrocytes
Current Signal Transduction Therapy How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry Network-Based Strategies Can Help Mono- and Poly-pharmacology Drug Discovery: A Systems Biology View
Current Pharmaceutical Design Recent Developments in PET Instrumentation
Current Pharmaceutical Biotechnology Semi-Quantitative Ultrasonographic Evaluation of NAFLD
Current Pharmaceutical Design